Immuno-oncology 360°

Feb 26 from 11:00 AM EST to Feb 28, 2020

Session: IO Novel Technologies
Title: “Clinical Updates for Advaxis’ Pipeline of Lm-based Immunotherapies in

Presenter:  Andres A. Gutierrez MD PhD – Advaxis’ Chief Medical Officer and Executive Vice President  
Date: Thursday, February 27, 2020
Time: 11:00 am ET


New York, New York